Patents by Inventor Su Hyun Jung

Su Hyun Jung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11059435
    Abstract: Disclosed is a vehicle software control device which includes hardware, a kernel connected to the hardware and configured to execute a first operating system, a system library connected to the kernel, a first connecting unit configured to connect a library for a second operating system different from the first operating system to the system library, and a first application executed on the second operating system.
    Type: Grant
    Filed: November 30, 2018
    Date of Patent: July 13, 2021
    Assignee: DRIMAES, INC.
    Inventors: Jin Woo Im, Guk Tae Kim, Won Lee, Soo Yeon Kang, Young Moon Jung, Su Chang Ko, Kyung Hyun Lim, Hong Lee
  • Patent number: 10980829
    Abstract: The present invention relates to a composition for dermal injection which includes two or more types of cross-linked hyaluronic acid particles having different particle diameters and non-cross-linked hyaluronic acid. The composition for dermal injection according to the present invention satisfies viscosity, extrusion force, and viscoelasticity conditions for dermal injection, and an extrusion force deviation is low so that the user does not feel fatigue when the composition is injected into the dermal thereof. Also, the composition is excellent in viscoelasticity and tissue restoring ability, is maintained for a long period of time, allows rapid recovery because an initial swelling degree is low, and also is excellent in safety and stability in the body.
    Type: Grant
    Filed: February 27, 2018
    Date of Patent: April 20, 2021
    Assignees: CG Bio Co., Ltd., DNCompany, Daewoong Pharmaceutical Co., Ltd.
    Inventors: Ji Sun Lee, Su Hyun Jung, Hak Su Jang, Jung Eun Choo, Hye Young Jung
  • Publication number: 20200061241
    Abstract: The present invention relates to a composition for dermal injection which includes two or more types of cross-linked hyaluronic acid particles having different particle diameters and non-cross-linked hyaluronic acid. The composition for dermal injection according to the present invention satisfies viscosity, extrusion force, and viscoelasticity conditions for dermal injection, and an extrusion force deviation is low so that the user does not feel fatigue when the composition is injected into the dermal thereof. Also, the composition is excellent in viscoelasticity and tissue restoring ability, is maintained for a long period of time, allows rapid recovery because an initial swelling degree is low, and also is excellent in safety and stability in the body.
    Type: Application
    Filed: February 27, 2018
    Publication date: February 27, 2020
    Applicants: CG Bio Co., Ltd., DNCompany, Daewoong Pharmaceutical Co., Ltd.
    Inventors: Ji Sun LEE, Su Hyun JUNG, Hak Su JANG, Jung Eun CHOO, Hye Young JUNG
  • Publication number: 20200016191
    Abstract: The present invention relates to a composition for dermal injection which includes two or more types of cross-linked hyaluronic acid particles having different particle diameters and non-cross-linked hyaluronic acid. The composition for dermal injection according to the present invention satisfies viscosity, extrusion force, and viscoelasticity conditions for dermal injection, and an extrusion force deviation is low so that the user does not feel fatigue when the composition is injected into the dermal thereof. Also, the composition is excellent in viscoelasticity and tissue restoring ability, is maintained for a long period of time, allows rapid recovery because an initial swelling degree is low, and also is excellent in safety and stability in the body.
    Type: Application
    Filed: February 27, 2018
    Publication date: January 16, 2020
    Applicants: CG Bio Co., Ltd., DNCompany, Daewoong Pharmaceutical Co., Ltd.
    Inventors: Ji Sun LEE, Su Hyun JUNG, Hak Su JANG, Jung Eun CHOO, Hye Young JUNG
  • Publication number: 20190374457
    Abstract: The present invention relates to a composition for dermal injection which includes two or more types of cross-linked hyaluronic acid particles having different particle diameters and non-cross-linked hyaluronic acid. The composition for dermal injection according to the present invention satisfies viscosity, extrusion force, and viscoelasticity conditions for dermal injection, and an extrusion force deviation is low so that the user does not feel fatigue when the composition is injected into the dermal thereof. Also, the composition is excellent in viscoelasticity and tissue restoring ability, is maintained for a long period of time, allows rapid recovery because an initial swelling degree is low, and also is excellent in safety and stability in the body.
    Type: Application
    Filed: February 27, 2018
    Publication date: December 12, 2019
    Applicants: CG Bio Co., Ltd., DNCompany, Daewoong Pharmaceutical Co., Ltd.
    Inventors: Ji Sun LEE, Su Hyun JUNG, Hak Su JANG, Jung Eun CHOO, Hye Young JUNG
  • Publication number: 20180344896
    Abstract: Provided are a hyaluronic acid composition having excellent viscoelasticity and being easily injectable, and a preparation method thereof.
    Type: Application
    Filed: September 2, 2015
    Publication date: December 6, 2018
    Inventors: Su Hyun JUNG, Jun Hyuk SEO, Hyun Seung RYU, Hak Su JANG
  • Patent number: 9925306
    Abstract: The present invention relates to a carrier for growth factor related to regeneration of bone tissues that is capable of arbitrarily controlling the delivery rate of growth factors related to bone regeneration and thus especially applicable to a bone void filler in the fields of the dental or orthopedic applications. The carrier for controlling the delivery rate of the growth factor in the present invention is composed of a hyaluronic acid hydrogel having a distribution of interconnected pores and a calcium phosphate microsphere being distributed in the pores of the hyaluronic acid hydrogel. The calcium phosphate microsphere having a porosity suitable for delivery of the growth factor is positioned into the pores of the cross-linked hyaluronic acid hydrogel to complete the carrier.
    Type: Grant
    Filed: January 9, 2017
    Date of Patent: March 27, 2018
    Assignee: Bioalpha Inc.
    Inventors: Jung Ju Kim, Su Hyun Jung, Hyun Seung Ryu, Jun Hyuk Seo
  • Patent number: 9735295
    Abstract: An electronic device with an electrode having a superior light transmittance and including a substrate, an amine group-containing compound layer formed on the substrate, and a metal layer formed on the amine group-containing compound layer is provided. In accordance with the present invention, the electrode is easily manufactured when a solution process is used, has performances of a light transmittance, a sheet resistance, and flexibility higher than those of a typical ITO transparent electrode, and a manufacturing cost of the electrode may be reduced.
    Type: Grant
    Filed: August 25, 2014
    Date of Patent: August 15, 2017
    Assignee: GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY
    Inventors: Kwang Hee Lee, Su Hyun Jung, Hong Kyu Kang
  • Publication number: 20170112969
    Abstract: The present invention relates to a carrier for growth factor related to regeneration of bone tissues that is capable of arbitrarily controlling the delivery rate of growth factors related to bone regeneration and thus especially applicable to a bone void filler in the fields of the dental or orthopedic applications. The carrier for controlling the delivery rate of the growth factor in the present invention is composed of a hyaluronic acid hydrogel having a distribution of interconnected pores and a calcium phosphate microsphere being distributed in the pores of the hyaluronic acid hydrogel. The calcium phosphate microsphere having a porosity suitable for delivery of the growth factor is positioned into the pores of the cross-linked hyaluronic acid hydrogel to complete the carrier.
    Type: Application
    Filed: January 9, 2017
    Publication date: April 27, 2017
    Inventors: JUNG JU KIM, SU HYUN JUNG, HYUN SEUNG RYU, JUN HYUK SEO
  • Publication number: 20160233357
    Abstract: An electronic device with an electrode having a superior light transmittance and including a substrate, an amine group-containing compound layer formed on the substrate, and a metal layer formed on the amine group-containing compound layer is provided. In accordance with the present invention, the electrode is easily manufactured when a solution process is used, has performances of a light transmittance, a sheet resistance, and flexibility higher than those of a typical ITO transparent electrode, and a manufacturing cost of the electrode may be reduced.
    Type: Application
    Filed: August 25, 2014
    Publication date: August 11, 2016
    Inventors: Kwang Hee LEE, Su Hyun JUNG, Hong Kyu KANG
  • Publication number: 20160056143
    Abstract: A light emitting device package include: a lead frame having one surface with a recess portion provided therein and including a first mounting region positioned on the one surface and a second mounting region positioned in the recess portion; a light emitting device mounted on the first mounting region and electrically connected to the lead frame; and a Zener diode mounted on the second mounting region and connected to the lead frame by a wire. The wire is positioned within the recess portion and is disposed to have a height lower than the first mounting region.
    Type: Application
    Filed: June 25, 2015
    Publication date: February 25, 2016
    Inventors: Jung Kyu PARK, Young Geun JUN, Su Hyun JUNG
  • Publication number: 20150182666
    Abstract: The present invention relates to a carrier for growth factor related to regeneration of bone tissues that is capable of arbitrarily controlling the delivery rate of growth factors related to bone regeneration and thus especially applicable to a bone void filler in the fields of the dental or orthopedic applications. The carrier for controlling the delivery rate of the growth factor in the present invention is composed of a hyaluronic acid hydrogel having a distribution of interconnected pores and a calcium phosphate microsphere being distributed in the pores of the hyaluronic acid hydrogel. The calcium phosphate microsphere having a porosity suitable for delivery of the growth factor is positioned into the pores of the cross-linked hyaluronic acid hydrogel to complete the carrier.
    Type: Application
    Filed: March 30, 2012
    Publication date: July 2, 2015
    Applicant: BIOALPHA INC.
    Inventors: Jung Ju Kim, Su Hyun Jung, Hyun Seung Ryu, Jun Hyuk Seo